PAVmed Inc. Common Stock (PAVM)

Price$6.15

Value ScoreD

Growth ScoreC

Momentum ScoreF

Favorite Metrics

Price vs S&P 500 (26W)-57.95%

Price vs S&P 500 (4W)-32.31%

VGM Score35.34

Market Capitalization$44.37M

P/E Ratio (Annual)110.66x

All Metrics

Book Value / Share (Quarterly)$36.61

P/TBV (Annual)3.63x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-42.83%

Cash Flow / Share (Quarterly)$-5.64

Price vs S&P 500 (YTD)-17.31%

Gross Margin (TTM)-205.63%

Net Profit Margin (TTM)564.79%

EPS (TTM)$-17.84

10-Day Avg Trading Volume0.01M

EPS Excl Extra (TTM)$-17.84

EPS (Annual)$0.60

ROI (Annual)0.89%

Gross Margin (Annual)-207.04%

Net Profit Margin (5Y Avg)-6841.93%

Cash / Share (Quarterly)$2.10

P/E Basic Excl Extra (TTM)110.66x

Revenue Growth QoQ (YoY)420.00%

P/E Normalized (Annual)110.66x

ROA (Last FY)1.03%

Revenue Growth TTM (YoY)-97.63%

EBITD / Share (TTM)$-22.05

ROE (5Y Avg)-440.28%

Operating Margin (TTM)-30797.18%

Cash Flow / Share (Annual)$-5.64

P/B Ratio1.31x

P/B Ratio (Quarterly)0.19x

Net Income / Employee (Annual)$9,800

EV / Revenue (TTM)753.82x

Net Interest Coverage (TTM)-166.22x

ROA (TTM)0.92%

EV / EBITDA (TTM)1.22x

EPS Incl Extra (Annual)$0.60

Current Ratio (Annual)0.17x

Quick Ratio (Quarterly)0.15x

3-Month Avg Trading Volume0.69M

52-Week Price Return-66.42%

P/E Incl Extra (TTM)110.66x

Revenue / Employee (TTM)$1,700

Tangible BV / Share (Quarterly)$0.05

P/S Ratio (Annual)624.97x

Asset Turnover (Annual)0.00x

52-Week High$28.44

Operating Margin (5Y Avg)-13979.48%

EPS Excl Extra (Annual)$0.60

CapEx CAGR (5Y)-12.37%

26-Week Price Return-42.02%

Quick Ratio (Annual)0.15x

13-Week Price Return-39.29%

Total Debt / Equity (Annual)0.33x

Current Ratio (Quarterly)0.17x

Enterprise Value$53.52M

Asset Turnover (TTM)0.00x

Revenue / Employee (Annual)$1,700

Pretax Margin (Annual)-3477.46%

Cash / Share (Annual)$2.10

3-Month Return Std Dev61.09%

Gross Margin (5Y Avg)-260.22%

Net Income / Employee (TTM)$9,800

ROE (Last FY)1.18%

Net Interest Coverage (Annual)-0.22x

EPS Basic Excl Extra (Annual)$0.60

Receivables Turnover (TTM)4.30x

Total Debt / Equity (Quarterly)0.33x

EPS Incl Extra (TTM)$-17.84

Receivables Turnover (Annual)4.30x

ROI (TTM)0.85%

P/S Ratio (TTM)624.97x

Pretax Margin (5Y Avg)-8831.06%

Revenue / Share (Annual)$0.11

Tangible BV / Share (Annual)$0.69

Price vs S&P 500 (52W)-94.63%

P/E Ratio (TTM)110.66x

Year-to-Date Return-6.37%

5-Day Price Return-3.00%

EPS Normalized (Annual)$0.60

ROA (5Y Avg)-57.14%

Net Profit Margin (Annual)564.79%

Month-to-Date Return-25.32%

Cash Flow / Share (TTM)$-0.82

EBITD / Share (Annual)$-32.45

Operating Margin (Annual)-30794.37%

ROI (5Y Avg)-120.16%

P/E Excl Extra (TTM)110.66x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-17.84

P/TBV (Quarterly)15.65x

P/B Ratio (Annual)0.19x

Inventory Turnover (TTM)34.81x

Pretax Margin (TTM)-3477.46%

Book Value / Share (Annual)$36.61

Price vs S&P 500 (13W)-49.04%

Beta0.58x

Revenue / Share (TTM)$0.08

ROE (TTM)1.02%

52-Week Low$6.00

vGradeD

gGradeC

mGradeF

vgmGradeD

Show chart for

Earnings Surprise History

Q1 26-4.42est. -0.71

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.13

Industry Peers — Surgical & Medical Instruments(138)

Symbol	Value Score	Growth Score	Momentum Score	Price
PAVMPAVmed Inc. Common Stock	D	C	F	$6.15
SYKStryker Corporation	C	C	D	$299.46
MMM3M Company	C	F	C	$150.93
BSXBoston Scientific Corp.	C	B	F	$47.98
MDLNMedline Inc. Class A common stock	C	D	D	$35.75
BDXBecton, Dickinson and Co.	B	C	C	$145.33
DXCMDexCom, Inc.	C	B	C	$74.87
RMDResMed Inc.	B	B	D	$186.44
WSTWest Pharmaceutical Services, Inc.	D	C	B	$316.30
SOLVSolventum Corporation	C	D	C	$75.84
PENPenumbra, Inc.	F	C	C	$318.95

About

PAVmed Inc is a commercial-stage medical technology company developing products across diagnostics, medical devices, and digital health. Its portfolio includes EsoGuard, esocheck, and the Veris Cancer Care Platform. The company is advancing its pipeline through commercialization to serve multiple healthcare markets.